Sebastian Hölzle

Sales Director HOME Therapies @ Fresenius Medical Care GmbH

Sorry, unable to follow Sebastian. Please try again.

About

Experienced hands-on Sales, Product- and Marketing Manager for the Dialysis-Eco-System, including Pharmaceuticals, IT Systems, Medical Products and Medical Devices. Highly motivated and driven by innovation and accountability, with a mission to encourage teams, transforming the medical business into the digital world as well as fostering sales.

Experience

  • Fresenius Medical Care (16 yrs 7 mos)
    • Sales Director Home Therapies
      Jan 2023 - Present · 3 yrs 10 mos

      Lead and guide the Home Sales Team Initiate hybrid/ remote sales campaigns Foster the digital transformation Optimize profitability and revenue streams Create and establish business and pricing models

    • Group Lead: Marketing and Product Management HOME Therapies
      Jan 2017 - Dec 2022 · 6 yrs

      Strategy and tactics development, implementation and reporting; Process improvements e.g. offer management; Pricing, cost- and profit calculation, business cases; KOL and customer management; Sales training and support; Launch of new products and services; Team development.

    • International (Senior) Product Manager Peritoneal-Dialysis Systems
      Jul 2014 - Dec 2016 · 2 yrs 6 mos

      Strategy development for all PD-devices in the EMEA region with phase in/ phase out scenario planning and implementation; Product-, market- and customer segmentation; Launch and rollout of a new device for the global market as well as uniting the market needs/ requirements and steering of R&D activities; International sales and customer care; Project lead with external companies e.g. market research.

    • Technical (Junior) Product Manager Peritoneal-Dialysis
      Apr 2010 - Jun 2014 · 4 yrs 3 mos

      Life cycle management of products; New development and optimizing of peritoneal dialysis devices closely with R&D; Workflow analysis; Training of employees; Driving the integration of acquisition-products into the portfolio.